Latest Insider Transactions at Adma Biologics, Inc. (ADMA)
This section provides a real-time view of insider transactions for Adma Biologics, Inc. (ADMA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ADMA BIOLOGICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ADMA BIOLOGICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 18
2023
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
250,000
-9.91%
|
$1,000,000
$4.15 P/Share
|
|
Aug 16
2023
|
Brian Lenz EVP, CFO |
SELL
Open market or private sale
|
Direct |
178,184
-18.56%
|
$712,736
$4.45 P/Share
|
|
Aug 16
2023
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
3
-0.0%
|
$12
$4.38 P/Share
|
|
Aug 15
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
631,078
-39.66%
|
$2,524,312
$4.61 P/Share
|
|
Aug 15
2023
|
Brian Lenz EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
809,262
+9.97%
|
$1,618,524
$2.92 P/Share
|
|
Aug 15
2023
|
Brian Lenz EVP, CFO |
SELL
Open market or private sale
|
Direct |
211,578
-21.29%
|
$846,312
$4.6 P/Share
|
|
Aug 15
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,589,987
-38.66%
|
$6,359,948
$4.61 P/Share
|
|
Aug 15
2023
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
510,469
-11.04%
|
$2,041,876
$4.54 P/Share
|
|
Aug 15
2023
|
Adam S Grossman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100,459
+8.73%
|
$4,200,918
$2.92 P/Share
|
|
Jun 30
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,051
-0.79%
|
$60,153
$3.69 P/Share
|
|
Jun 30
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,268
-1.51%
|
$45,804
$3.69 P/Share
|
|
Mar 31
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,853
-0.7%
|
$53,559
$3.31 P/Share
|
|
Mar 31
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,469
-1.51%
|
$46,407
$3.31 P/Share
|
|
Mar 07
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,965
-1.63%
|
$50,895
$3.4 P/Share
|
|
Mar 07
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,607
-0.91%
|
$70,821
$3.4 P/Share
|
|
Mar 06
2023
|
Bryant Fong |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+30.12%
|
-
|
|
Mar 06
2023
|
Young Kwon |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+9.28%
|
-
|
|
Mar 06
2023
|
Martha J Demski |
BUY
Grant, award, or other acquisition
|
Indirect |
25,815
+31.32%
|
-
|
|
Mar 06
2023
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+16.58%
|
-
|
|
Mar 06
2023
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+33.0%
|
-
|
|
Mar 06
2023
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
25,815
+7.61%
|
-
|
|
Mar 06
2023
|
Brian Lenz EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
135,175
+11.49%
|
-
|
|
Mar 06
2023
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
573,695
+18.16%
|
-
|
|
Feb 28
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,000
-0.55%
|
$15,000
$3.55 P/Share
|
|
Feb 28
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,507
-0.37%
|
$22,521
$3.55 P/Share
|
|
Feb 25
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,486
-0.52%
|
$28,458
$3.42 P/Share
|
|
Feb 25
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,430
-0.45%
|
$55,290
$3.42 P/Share
|
|
Jan 04
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
114,222
-11.04%
|
$342,666
$3.87 P/Share
|
|
Jan 04
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
166,867
-7.57%
|
$500,601
$3.87 P/Share
|
|
Dec 09
2022
|
Brian Lenz EVP, CFO |
BUY
Open market or private purchase
|
Direct |
6,993
+0.67%
|
$13,986
$2.86 P/Share
|
|
Dec 09
2022
|
Adam S Grossman President and CEO |
BUY
Open market or private purchase
|
Indirect |
14,982
+1.29%
|
$29,964
$2.86 P/Share
|
|
Dec 09
2022
|
Adam S Grossman President and CEO |
BUY
Open market or private purchase
|
Direct |
14,983
+0.68%
|
$29,966
$2.86 P/Share
|
|
Sep 30
2022
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
101,315
-4.42%
|
$202,630
$2.43 P/Share
|
|
Sep 30
2022
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,678
-6.69%
|
$147,356
$2.43 P/Share
|
|
May 11
2022
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
70,004
-2.97%
|
$70,004
$1.43 P/Share
|
|
May 11
2022
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
51,965
-4.51%
|
$51,965
$1.43 P/Share
|
|
Mar 23
2022
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,539
-2.1%
|
$50,539
$1.46 P/Share
|
|
Mar 23
2022
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,178
-3.12%
|
$37,178
$1.46 P/Share
|
|
Mar 07
2022
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+8.47%
|
-
|
|
Mar 07
2022
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+11.07%
|
-
|
|
Mar 07
2022
|
Martha J Demski |
BUY
Grant, award, or other acquisition
|
Indirect |
26,586
+46.34%
|
-
|
|
Mar 07
2022
|
Brian Lenz EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
137,500
+10.35%
|
-
|
|
Mar 07
2022
|
Bryant Fong |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+43.82%
|
-
|
|
Mar 07
2022
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+20.35%
|
-
|
|
Mar 07
2022
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+50.0%
|
-
|
|
Mar 07
2022
|
Young Kwon |
BUY
Grant, award, or other acquisition
|
Direct |
26,586
+10.5%
|
-
|
|
Oct 25
2021
|
Adam S Grossman President and CEO |
BUY
Open market or private purchase
|
Indirect |
250,000
+18.14%
|
$250,000
$1.0 P/Share
|
|
Oct 25
2021
|
Adam S Grossman President and CEO |
BUY
Open market or private purchase
|
Direct |
100,000
+4.47%
|
$100,000
$1.0 P/Share
|
|
Oct 25
2021
|
Brian Lenz EVP, CFO |
BUY
Open market or private purchase
|
Direct |
30,000
+2.74%
|
$30,000
$1.0 P/Share
|
|
Oct 25
2021
|
Jerrold B Grossman |
BUY
Open market or private purchase
|
Direct |
100,000
+27.71%
|
$100,000
$1.0 P/Share
|